SEARCH

SEARCH BY CITATION

References

  • 1
    Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003; 196: 5164.
  • 2
    Campos L, Naji A, Deli BC et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187191.
  • 3
    Han WR, Murray-Segal LJ, Mottram PL. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients. Transpl Immunol 1999; 7: 3744.
  • 4
    Mottram PL, Raisanen-Sokolowski A, Glysing-Jensen T, Stein-Oakley AN, Russell ME. Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: Vascular and cytokine analysis after transient CD4 T cell depletion. Transplantation 1998; 66: 15101518.
  • 5
    He G, Kim OS, Thistlethwaite JR et al. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc 1999; 31: 12391241.
  • 6
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199204.
  • 7
    Yamada A, Kishimoto K, Dong VM et al. CD28-independent costimulation of T cells in alloimmune responses. J Immunol 2001; 167: 140146.
  • 8
    Szot GL, Zhou P, Rulifson I et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1: 3846.
  • 9
    Maier S, Tertilt C, Chambron N et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7: 557562.
  • 10
    Chambers BJ, Salcedo M, Ljunggren HG. Triggering of natural killer cells by the costimulatory molecule CD80 (B7–1). Immunity 1996; 5: 311317.
  • 11
    Hobbs JA, Cho S, Roberts TJ et al. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J Virol 2001; 75: 1074610754.
  • 12
    Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 2001; 166: 60126018.
  • 13
    George TC, Mason LH, Ortaldo JR, Kumar V, Bennett M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol 1999; 162: 20352043.
  • 14
    Chen YH, Chiu NM, Mandal M, Wang N, Wang CR. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997; 6: 459467.
  • 15
    Ogasawara K, Hamerman JA, Ehrlich LR et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20: 757767.
  • 16
    Zhou P, Balin SJ, Mashayekhi M, Hwang KW, Palucki DA, Alegre ML. Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL. J Immunol 2005; 174: 34473453.
  • 17
    Lee KM, McNerney ME, Stepp SE et al. 2B4 acts as a non-Major Histocompatibility Complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004; 199: 12451254.
  • 18
    Petersson E, Ostraat O, Ekberg H et al. Allogeneic heart transplantation activates alloreactive NK cells. Cell Immunol 1997; 175: 2532.
  • 19
    Boles KS, Stepp SE, Bennett M, Kumar V, Mathew PA. 2B4 (CD244) and CS1: Novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol Rev 2001; 181: 234249.
  • 20
    Glimcher L, Shen FW, Cantor H. Identification of a cell-surface antigen selectively expressed on the natural killer cell. J Exp Med 1977; 145: 19.
  • 21
    Ballas Z, Rasmussen W. NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset. J Immunol 1990; 145: 10391045.
  • 22
    Yu YY, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992; 10: 189213.
  • 23
    Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151: 6070.
  • 24
    Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675678.
  • 25
    Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225274.
  • 26
    Anderson SK, Ortaldo JR, McVicar DW. The ever-expanding Ly49 gene family: Repertoire and signaling. Immunol Rev 2001; 181: 7989.
  • 27
    Salcedo M, Diehl AD, Olsson-Alheim MY et al. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol 1997; 158: 31743180.
  • 28
    George TC, Ortaldo JR, Lemieux S, Kumar V, Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol 1999; 163: 18591867.
  • 29
    Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood 2002; 100: 30263033.
  • 30
    Robson MacDonald H, Lees RK, Held W. Developmentally regulated extinction of Ly-49 receptor expression permits maturation and selection of NK1.1+ T cells. J Exp Med 1998; 187: 21092114.
  • 31
    Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol 1998; 160: 8794.
  • 32
    Mason LH, Anderson SK, Yokoyama WM, Smith HR, Winkler-Pickett R, Ortaldo JR. The Ly-49D receptor activates murine natural killer cells. J Exp Med 1996; 184: 21192128.
  • 33
    Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781790.
  • 34
    Hankey KG, Drachenberg CB, Papadimitriou JC et al. MIC expression in renal and pancreatic allografts. Transplantation 2002; 73: 304306.
  • 35
    Lodoen M, Ogasawara K, Hamerman JA et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 2003; 197: 12451253.
  • 36
    Koike J, Wakao H, Ishizuka Y et al. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I. J Exp Med 2004; 199: 137144.
  • 37
    Beilke JN, Kuhl NR, Kaer LV, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11: 10591065.
  • 38
    Moretta A. Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2002; 2: 957964.
  • 39
    Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 2004; 173: 37163724.
  • 40
    Assarsson E, Kambayashi T, Schatzle JD et al. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 2004; 173: 174180.
  • 41
    Kondo T, Morita K, Watarai Y et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69: 969977.
  • 42
    Bender JR, Pardi R, Kosek J, Engleman EG. Evidence that cytotoxic lymphocytes alter and traverse allogeneic endothelial cell monolayers. Transplantation 1989; 47: 10471053.
  • 43
    Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, Colvin RB. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001; 167: 57315740.
  • 44
    Bishara A, Brautbar C, Eid A, Sherman L, Safadi R. Killer inhibitory receptor mismatching and liver transplantation outcome. Transplant Proc 2001; 33: 2908.
  • 45
    Vampa ML, Norman PJ, Burnapp L, Vaughan RW, Sacks SH, Wong W. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Transplantation 2003; 76: 12201228.